Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
Haematologica|December 3, 2011
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trialMartin Kropff, Honorata Giongco Baylon, Jens Hillengass, et al.
British Journal of Haematology|October 9, 2023
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapyOndrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, et al.
The Lancet. Oncology|September 24, 2013
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind studyMeletios Dimopoulos, David S Siegel, Sagar Lonial, et al.
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
Leukemia & Lymphoma|October 26, 2011
Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trialPavel Nemec, Zuzana Zemanova, Petr Kuglik, et al.
British Journal of Haematology|July 9, 2015
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-upHeinz Ludwig, Richard Greil, Tamas Masszi, et al.
Haematologica|May 28, 2017
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myelomaAneta Mikulasova, Christopher P Wardell, Alexander Murison, et al.
Hemasphere|October 7, 2022
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple MyelomaPieter Sonneveld, Sonja Zweegman, Michele Cavo, et al.
Annals of Hematology|August 18, 2025
De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysisMartin Stork, Jakub Radocha, Jana Mihalyova, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCRDaniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Pageof 22